Subscribe

Featured Content

    Top Trending Articles

    FDA Approvals, News & Updates

    Highlights from the Latest Issue: December 2023, Vol 14, No 6

    Value-Based Care

    Personalized Medicine | Browse By Specialty

    Hematologic Malignancies

    Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
    Phoebe Starr
    Chicago, IL—Interim results from the phase 3 COMMANDS trial demonstrated that first-line treatment with luspatercept-aamt (Reblozyl) increased hemoglobin levels and enabled nearly twice as many patients with transfusion-dependent, lower-risk myelodysplastic syndromes (MDS) to avoid red blood cell transfusions during the first 24 weeks of the study compared with standard-of-care epoetin alfa.
    Read Article

    Quick Quiz: Chronic Myeloid Leukemia

    Quick Quiz: Chronic Myeloid Leukemia

    Chronic myeloid leukemia, also known as chronic myelogenous leukemia, is a malignancy that originates in blood-forming cells (called myeloid cells) found in bone marrow. How much do you know about chronic myeloid leukemia?

    Start the Quiz

    10th AVBCC Summit Agenda

    New speakers are being added weekly, please be sure to check back often!

    To view detailed session information, including start times, session overviews, and faculty listings, please click on a title below.

    Not sure which sessions to attend? Download our guide to navigating the AVBCC Summit.

    AVBCC 2020 Summit Track Agenda

    *Agenda subject to change.

    • Tuesday, October 13, 2020
    • Washington Perspectives on Cancer Care
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EDT
    • 5:00 am – 6:30 am PDT
    • Rebroadcast
    • 7:30 pm – 9:00 pm EDT
    • 4:30 pm – 6:00 pm PDT

    Overview

    Washington public policy and legislative actions impact the cancer care market greater than any other health payer group as 50% of the cancer population is financially supported under Medicare and another 10% under Medicaid coverage. This panel of Washington K Street experts will discuss the current and prospective policy and legislative initiatives that will impact cancer care in the near future given the pending election.

    Speakers

    Moderator

    • Jayson Slotnik, JD, MPHManaging Partner, Health Policy Strategies

    Faculty

    • Joe Grogan, JDFormer Assistant to the President, Director, Domestic Policy Council
    • Deborah Kamin, RN, PhDVP, Policy & Advocacy, American Society of Clinical Oncology
    • Ipsita Smolinski, MBAManaging Director, Capitol Street
    • Barrett Thornhill, JDPartner, Forbes Tate Partners
    • Zach WilliamsManaging Partner, Forbes Tate Partners
    • Wednesday, October 14, 2020
    • Employers' Perspectives on Cancer Care
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EDT
    • 5:00 am – 6:30 am PDT
    • Rebroadcast
    • 7:30 pm – 9:00 pm EDT
    • 4:30 pm – 6:00 pm PDT

    Overview

    Employers have taken a greater interest in balancing affordable access to cancer care given the complexity of delivering cancer care. Employers also struggle with the fact that creating a benefit design and access that works for cancer patients at times is in conflict with one-size-fits-all benefit structures. Panelists will discuss the relationship between workplaces, coverage, cancer care, and new emerging models of care and payment, and barriers to accountable care.

    Speakers

    Moderator

    • J. Leonard Lichtenfeld, MD, MACPFormer Deputy Chief Medical Officer, American Cancer Society

    Faculty

    • Robert Baird, RN, MSAPresident, National Cancer Treatment Alliance
    • Adam Bradley, BACo-Founder, Cancer Study Group
    • Oren Cahlon, MDDeputy Physician-in-Chief, Strategic Partnerships; Vice Chair, Department of Radiation Oncology, Memorial Sloan Kettering Center of Excellence
    • Patricia GoldsmithCEO, CancerCare
    • Harlan Levine, MDPresident, Strategy and Business Ventures, City of Hope
    • Bhuvana Sagar, MDNational Medical Executive, Cigna Health Care
    • Thursday, October 15, 2020
    • Practice Transformation through Value-Based Analytics
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EDT
    • 5:00 am – 6:30 am PDT
    • Rebroadcast
    • 7:30 pm – 9:00 pm EDT
    • 4:30 pm – 6:00 pm PDT

    Overview

    Cancer care is expensive, and oncologists and payers continue to iterate on value-based reimbursement models that strive to fairly incentivize high-quality care. Forward-thinking practices seek meaningful analytics into how they deliver care and actionable insights that identify potential investments in care transformation to improve outcomes. This panel will include analytics and value-based care experts as well as frontline practice leaders who offer tactical solutions for practice transformation.

    Speakers

    Moderators

    • James Hamrick, MD, MPHSenior Medical Director, Clinical Oncology, Flatiron Health
    • Charles Saunders, MDCEO, Integra Connect

    Faculty

    • Sibel Blau, MDPresident & CEO, Quality Cancer Care Alliance Network; Medical Director, Oncology Division, Northwest Medical Specialties
    • Basit Chaudhry, MD, PhDFounder & CEO, Tuple Health
    • Nina Chavez, MBA, FACMPEHead, VBC Solutions and Transformtion, Flatiron Health
    • Lucio Gordan, MDPresident, Florida Cancer Specialists
    • Friday, October 16, 2020
    • Cancer Care and the 340B Program
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    The 340B program, created by Congress in 1992, sought to help vulnerable and uninsured patients access prescription medicines at safety-net facilities. Since 1992, there has been a vast expansion of this program, but the program has had unintended consequences that are in conflict with the original mission and goals. This panel will debate the headwinds and tailwinds and what needs to stay or be fixed to keep this program viable in the future for all stakeholders.

    Speakers

    Moderator

    • Jayson Slotnik, JD, MPHManaging Partner, Health Policy Strategies

    Faculty

    • Jeremy DockenCEO, Kalderos
    • Ross HalsneVP, Operations, Maxor National Pharmacy Services, LLC
    • Richard Kanner, MBASenior Director, Oncology Market Access, Eli Lilly and Company
    • Douglas Neely, CMPE, MHABiopharmaceutical/Oncology Pricing, Value, Market Access & Trade Leader, Athenex
    • Shannon Stephenson, CPACEO, Cempa Community Care
    • Tuesday, October 20, 2020
    • Payers' Perspectives on Cancer Care
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EDT
    • 5:00 am – 6:30 am PDT
    • Rebroadcast
    • 7:30 pm – 9:00 pm EDT
    • 4:30 pm – 6:00 pm PDT

    Overview

    Managed care commercial market makers have increasingly stepped up in their innovation, oversight, and responses to the escalating cost of cancer care in the past year. Applying the right solutions and tactics is no easy fiduciary task when balancing costs with value. This panel will discuss lessons learned from the past and the new paths to the future ahead between cancer providers and managed care market makers to deliver value and care in community settings and large cancer care settings.

    Speakers

    Moderator

    • Michael Kolodziej, MDSenior Advisor, ADVI Health

    Faculty

    • Roger Brito, DODivision Head, Enterprise Oncology, CVS Health
    • Sarah Duggan Goldstein, MPHSenior Clinical Consultant, Blue Cross Blue Shield Association
    • Ira Klein, MD, MBA, FACPChief Medical Officer, Health New England
    • Steven Peskin, MD, MBA, FACPExecutive Medical Director, Population Health and Transformation, Horizon Blue Cross Blue Shield
    • Bryan Loy, MD, MBA,Physician Lead, Oncology, Laboratory, and Personalized Medicine, Humana
    • Bruce Pyenson, FSA, MAAAPrincipal & Consulting Actuary, Milliman
    • Michael Sherman, MD, MBA, MSSVP & Chief Medical Officer, Harvard Pilgrim Healthcare
    • Wednesday, October 21, 2020
    • Community Providers' Perspectives on Cancer Care
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EDT
    • 5:00 am – 6:30 am PDT
    • Rebroadcast
    • 7:30 pm – 9:00 pm EDT
    • 4:30 pm – 6:00 pm PDT

    Overview

    Fifty-five percent of cancer care is delivered in the community and alternate local sites of care around the country today. Community-based cancer care remains the core of the cancer care delivery system. This panel will explore the road ahead in balancing value and delivering optimal access to care.

    Speakers

    Moderator

    • Clifford Hudis, MD, FACP, FASCOCEO, American Society of Clinical Oncology

    Faculty

    • Sibel Blau, MDPresident & CEO, Quality Cancer Care Alliance Network; Medical Director, Oncology Division, Northwest Medical Specialties
    • Carrie Dul, MD, FACPHematologist/Oncologist, Great Lakes Cancer Management Specialists
    • Lucio Gordan, MDPresident, Florida Cancer Specialists
    • Terrill Jordan, LLM, JDPresident & CEO, Regional Cancer Care Associates
    • Lee Schwartzberg, MDChief Medical Officer, OneOncology
    • Thursday, October 22, 2020
    • KeynoteA Look Ahead on Cancer Care with Greg Simon
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EDT
    • 5:00 am – 6:30 am PDT
    • Rebroadcast
    • 7:30 pm – 9:00 pm EDT
    • 4:30 pm – 6:00 pm PDT

    Overview

    Greg Simon is one of the foremost thought leaders in cancer care. He is the Past President, Biden Cancer Initiative, Washington, DC, the nonprofit organization that was built on the goals of the White House Cancer Moonshot program and Former Vice President Joe Biden and Dr Jill Biden’s commitment to double the rate of progress in preventing, detecting, diagnosing, treating, and surviving cancer. During his tenure, he helped to launch more than 70 innovative private and public–private collaborations and numerous novel interagency initiatives that helped support the successful effort to secure $1.8 billion in new funding for the Cancer Moonshot program. Mr Simon will discuss his perspectives on the future of cancer care delivery in the United States.

    Keynote Speaker

    • Greg Simon, JDConsultant & Pulib Speaker, Simonovation, LLC
    • Friday, October 23, 2020
    • Cancer Pharmaceuticals and the Value Equation
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EDT
    • 5:00 am – 6:30 am PDT
    • Rebroadcast
    • 7:30 pm – 9:00 pm EDT
    • 4:30 pm – 6:00 pm PDT

    Overview

    More information coming soon.

    Speakers

    Moderator

    • William McGivney, PhDManaging Principal, McGivney Global Advisors

    Faculty

    • Ravinder Dhawan, PhDVP & Head, Oncology, Center of Observational & Real-World Evidence, Merck
    • Anna Kaltenboeck, MASenior Health Economist & Program Director, Memorial Sloan Kettering Cancer Center
    • Avi Mamidi, PharmD, BCPSSenior Director, Access Experience Team, Precision Value
    • Tuesday, October 27, 2020
    • Cancer Center of Excellence and Integrated Health Delivery System Perspectives on Cancer Care
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EDT
    • 5:00 am – 6:30 am PDT
    • Rebroadcast
    • 7:30 pm – 9:00 pm EDT
    • 4:30 pm – 6:00 pm PDT

    Overview

    Complex cancer care in the United States is delivered in large measure but not exclusively by large institutional cancer centers and teaching hospital centers. The panel will discuss the current headwinds and tailwinds impacting large cancer care providers and their role in the future delivery of specialized cancer treatments and scientific advancement while balancing cost and value.

    Speakers

    Moderator

    • William McGivney, PhDManaging Principal, McGivney Global Advisors

    Faculty

    • Pat Basu, MD, MBAPresident & CEO, Cancer Treatment Centers of America Global
    • Howard Burris, III, MD, FACP, FASCOPresident & Chief Medical Officer, Sarah Cannon
    • Lisa DeAngelis, MDPhysician-in-Chief, Memorial Sloan Kettering Cancer Center
    • Harlan Levine, MDPresident, Strategy and Business Ventures, City of Hope
    • Wednesday, October 28, 2020
    • Pharmaceutical Industry Perspectives on Cancer Care
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EDT
    • 5:00 am – 6:30 am PDT
    • Rebroadcast
    • 7:30 pm – 9:00 pm EDT
    • 4:30 pm – 6:00 pm PDT

    Overview

    Innovative cancer drugs and biologics and other novel therapies come to the marketplace fueling additional challenges and headwinds for health plans, providers, governments, and patients to finance cancer treatments. Conversely, these new innovations deliver exponential value to all stakeholders. This panel will explore and discuss the value creation brought to the market through investment and research efforts in cancer care.

    Speakers

    Moderator

    • Michael Kolodziej, MDSenior Advisor, ADVI Health

    Faculty

    • Lauren Barnes, MHSSVP, Market Access, Blueprint Medicines
    • Jill DeSimoneSVP, US and Latin America, Oncology, Merck Oncology
    • John Doyle, MPH, DrPHVP, Global Healthcare Innovation Lead, Pfizer
    • Mitch Higashi, PhDVP, Health Economics & Outcomes Research, Bristol Myers Squibb
    • Marcus Neubauer, MDChief Medical Officer, The US Oncology Network
    • Thursday, October 29, 2020
    • Employers’ Perspective on Cancer Care Benefit Design and Access to Care
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EDT
    • 5:00 am – 6:30 am PDT
    • Rebroadcast
    • 7:30 pm – 9:00 pm EDT
    • 4:30 pm – 6:00 pm PDT

    Overview

    Employers, after Medicare, are the largest purchasing group in cancer care. They are also the “premium buyer” often paying 200%+ more than Medicare for the same service. The panel will share how they plan, budget, and manage their benefits annually, as well as present the information sources, tools, and resources they use in the process. Throughout, they will share their expectations for all stakeholders and providers in the cancer care ecosystem.

    Speakers

    Moderator

    • Art Taft, MBAPartner, Medworks Consulting, LLC

    Faculty

    • Karen van Caulil, PhDPresident & CEO, Florida Alliance for Healthcare Value
    • Joseph Dizenhouse, FSA, MAAASVP & Head of Pharmacy Services, HealthTrust
    • Murray HarberHealth Strategist, Farm Bureau Life Insurance Company
    • Carole Mendoza, MBAFormer Director, Global Health Benefits Strategy, Benefits Saving – Employee Engagement, IBM
    • Gerry Stanley, MDExecutive Consultant, COPE Health Solutions
    • Friday, October 30, 2020
    • Recruiting Minorities to Clinical Trials
    • 10th Association for Value-Based Cancer Care Summit

    Schedule

    • Live
    • 8:00 am – 9:30 am EDT
    • 5:00 am – 6:30 am PDT
    • Rebroadcast
    • 7:30 pm – 9:00 pm EDT
    • 4:30 pm – 6:00 pm PDT

    Overview

    More information coming soon.

    Speakers

    Moderators

    • Barry Fortner, PhDFormer President, Specialty Physician Services, AmerisourceBergen
    • Maurie Markman, MDPresident, Medicine & Science; Chief Clinical Officer, Cancer Treatment Centers of America

    Faculty

    • Barbara Bierer, MDFaculty Director, Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard
    • Andy LeeSVP, Head of Global Clinical Trial Operations, Merck Research Labs
    • Tamar ThompsonVP, Government Affairs & Policy, Alexion Pharmaceuticals, Inc.; Chairman of the Board, Alexion Charitable Foundation
    • Monday, November 2, 2020
    • HUB Support Services and the Impact on Cancer Care
    • 10th Association for Value-Based Cancer Care Summit
    Next Event
    11

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    Pharmaceutical manufacturers and providers alike rely on HUB Programs and Support Services to ensure cancer care is delivered on time and efficiently. This panel will explore the future of HUB Services.

    Speakers

    Moderator

    • Burt Zweigenhaft, PhD, D.Litt.Managing Partner Upstream Partners, Co-Founder, AVBCC

    Faculty

    • Kelly Franchetti, RN, CCRN, CENVP & Global Head Patient Insights & Strategy, YPrime
    • Jodie McVan, MBAVP, Agency Services and Operations, Mirador Global LP
    • Elizabeth Oyekan, PharmD, FCHSP, CPHQVP, Access Experience Team, PRECISIONvalue
    • Susan RaiolaPresident, Real Endpoints, LLC
    • Charles Stevens, JD, MBAChief Operating Officer, COPILOT
    • Wednesday, November 4, 2020
    • Oncology Pipeline, Innovation, and Trends
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    With 75% of the pharmaceutical research and development focused on cancer and oncology, this panel will explore the near-term innovative agents coming to market in the next year. Additionally, there will be a global presentation and discussion on US and worldwide cancer pharmaceutical trends.

    Speakers

    Moderator

    • Burt Zweigenhaft, PhD, D.Litt.Managing Partner Upstream Partners, Co-Founder, AVBCC

    Faculty

    • Jeffrey Bockman, PhDEVP, Cello Health BioConsulting (formerly Defined Health)
    • Doug LongVP, Industry Relations, IQVIA
    • William RothFounding Partner, Blue Fin Group
    • Thursday, November 5, 2020
    • KeynoteAn Industry Look Ahead on Cancer Care
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    This will be a keynote from industry leaders forecasting the waters ahead, also looking forward on the cancer care industry.

    Speakers

    Moderators

    • William McGivney, PhDManaging Principal, McGivney Global Advisors
    • Burt Zweigenhaft, PhD, D.Litt.Co-Founder, Association for Value-Based Cancer Care

    Faculty

    • Matthew Eyles, MSPresident & CEO, America’s Health Insurance Plans (AHIP)
    • Stephen UblPresident & CEO, Pharmaceutical Research and Manufacturers of America (AHIP)
    • Friday, November 6, 2020
    • Post-Election Cancer Care Forecast
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:00 am EST
    • 5:00 am – 6:00 am PST
    • Rebroadcast
    • 7:30 pm – 8:30 pm EST
    • 4:30 pm – 5:30 pm PST

    Overview

    The AVBCC Co-Chairs represent all segments of the industry. This panel will discuss stakeholder impact of the election results.

    Speakers

    Moderator

    • Burt Zweigenhaft, PhD, D.Litt.Co-Founder, Association for Value-Based Cancer Care

    Faculty

    • J. Leonard Lichtenfeld, MD, MACPFormer Deputy Chief Medical Officer, American Cancer Society
    • Jonathan Levitt, Esq.Co-Founding Partner, Frier Levitt, LLC
    • Pamela Pelizzari, MPHPrincipal & Healthcare Consultant, Milliman
    • Steven Peskin, MD, MBA, FACPEMD, Population Health and Transformation, Horizon BCBS
    • Chevon Rariy, MDNational Director, Telehealth, Cancer Treatment Centers of America
    • Lillie Shockney, RN, BS, MAS, HON-ONN-CGFounder, Association for Value-Based Cancer Care
    • Art Taft, MBA, MEngPartner, Medworks Consulting, LLC
    • Monday, November 9, 2020
    • Telehealth and Cancer Care
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    Telehealth and Cancer Care will feature the aspects of telemedicine which oncologists are turning to in order to extend the doctor/patient relationship beyond the cancer center. Joe Kvedar will feature his work with hi-resolution cameras to observe skin aberrations which could be precursors to cancer. Since much of post-tertiary care for cancer can be rendered outside of the hospital setting, Adam Dicker will explore side effect management, post chemotherapy or radiation, as practiced at Thomas Jefferson. GoMo Health’s founder and CEO, Bob Gold, will describe his bi-directional chatbot that reduces friction between a cancer patient and care assistance, including results from the Cancer Inst of NJ. Alexandra Drane will share her perspective of empowering caregivers; their reliance on digital tools and the vast amount of support they can tap into through a virtual health care world. Finally, Sue Zbikowski, a psychologist formerly with Humana, will address the challenges of activating and motivating cancer patients in virtual environments.

    Speakers

    Moderator

    • Rick LeeFounder, Quality Oncology, Value Health, Healthrageous, and MeYou Health

    Faculty

    • Adam Dicker, MD, PhD, FASTRO, FASCODirector, Jefferson Center for Digital Health
    • Alexandra DraneCo-Founder & CEO, Rebel Health & ARCHANGELS
    • Bob GoldChief Behavioral Technologist & CEO, GoMo Health
    • Joseph Kvedar, MDPresident-Elect, ATA
    • Sue Zbikowski, PhDCEO, inZights Consulting
    • Tuesday, November 10, 2020
    • Cancer Research, Investigational Studies Perspectives
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    Cancer research and investigational studies are delivering valuable treatments through massive capital investments, time, and effort, given the reality that most products will never make it through the process to approval, resulting in a high cost of failure.

    Speakers

    Moderator

    • James Hamrick, MD, MPHSenior Medical Director, Clinical Oncology, Flatiron Health

    Faculty

    • Björn Albrecht, PhDPartner, McKinsey & Company
    • Roger Brito, DODivision Head, Enterprise Oncology, CVS Health
    • Ibrahim Elhoussieny, MDVP, Global Head, Oncology and Cell Therapy Medical Affairs, Gilead Sciences
    • Blase Polite, MD, MPP, FASCOAssociate Professor of Medicine, University of Chicago
    • Maurie Markman, MDPresident, Medicine & Science; Chief Clinical Officer, Cancer Treatment Centers of America
    • Wednesday, November 11, 2020
    • Cancer Care Patient Advocacy Perspectives
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    Many vital patient support groups are struggling to survive in a post–COVID-19 world. Some advocacy organizations have endured or are facing massive layoffs, office closures, and funding decreases. In some extreme cases, this is forcing them to look for merger partners. As resources are depleted and demand grows, our panelists will discuss the future of patient advocacy groups and the vital role that they have in not only supporting patients and caregivers but also the academic and community oncology providers.

    Speakers

    Moderator

    • Lauren Barnes, MHSSVP, Market Access, Blueprint Medicines

    Faculty

    • Patricia GoldsmithCEO, CancerCare
    • J. Leonard Lichtenfeld, MD, MACPFormer Deputy Chief Medical Officer, American Cancer Society
    • Debra Patt, MD, PhD, MBAEVP, Policy and Strategic Initiatives, Texas Oncology
    • Lillie Shockney, RN, BS, MAS, HON-ONN-CGFounder, Academy of Oncology Nurse & Patient Navigators
    • Thursday, November 12, 2020
    • Legal Issues Around Structuring Value-Based Contracts
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    There is little doubt that value-based contracts (VBC) are the future of healthcare. Plan Sponsors must control the total cost of care, on both the healthcare and pharmacy benefits. CINs have emerged as a clear pathway for the celebration of “medical outcomes” over “fee for service”. However, many barriers to entry exist for the exploration of VBC. This program will explore the goals and opportunities presented by VBC, as well as identify both the hurdles and solutions.

    Speakers

    Moderator

    • Jonathan Levitt, EsqCo-Founding Partner, Frier Levitt, LLC

    Faculty

    • Sibel Blau, MDPresident & CEO, Quality Cancer Care Alliance Network; Medical Director, Oncology Division, Northwest Medical Specialties
    • Antonio CiacciaChief Strategy Officer, 3 Axis Advisors
    • Daniel Frier, EsqCo-Founding Partner, Frier Levitt, LLC
    • Eric Pachman, MBAFounder & Principal, 3 Axis Advisors
    • Ted Okon, MBAExecutive Director, Community Oncology Alliance
    • Kathy Oubre, MSChief Operations Officer, Pontchartrain Cancer Center
    • Friday, November 13, 2020
    • Telemedicine a Legal View on the Role of Technology and Changing Laws in the Delivery of Cancer Care
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    Advancements in technology often outpace changes in The Law. The lagging nature of the Law makes compliance with tricky. This program will explore some of the ways that technology can potentially improve patient care, leading to better outcomes in the delivery of cancer care. Some improvements in patient care and technology, however, can be a regulatory problem leading to recoupments or, worse yet, investigations. Providers and other Stakeholders must be weary of legal pitfalls.

    Speakers

    Moderator

    • Daniel Frier, Esq.Co-Founding Partner, Frier Levitt, LLC

    Faculty

    • Simone Colgan Dunlap, JDHealth Law Attorney & Partner, Quarles & Brady LLP
    • Anne Diamond, JD, CNMTPresident, Bridgeport Hospital
    • John Morrone, EsqPartner, Frier Levitt, LLC
    • Lorenzo Paladino, MDPhysician, Associate Professor, Emergency Medicine, SUNY Downstate and Kings County Medical Centers
    • Monday, November 16, 2020
    • Reimagining the Future of Cancer Care in the New Normal: Positive Learning Lessons in a Post–COVID-19 World
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    More information coming soon.

    Speakers

    Moderator

    • Ron DiGiaimo, MBA, FACHEChairman of the Board, Revenue Cycle, RCBilling, The Oncology Group

    Faculty

    • Carla Balch, AA, BPS, MSCEO & Founder, Spesana
    • Roberta Buell, MBAPrincipal, Provider Services & Reimbursement Information, onPoint Oncology, Inc.
    • Kathy Oubre, MSChief Operations Officer, Pontchartrain Cancer Center
    • Jeff Patton, MDCEO, OneOncology & Executive Chairman of the Board, Tennessee Oncology
    • Tuesday, November 17, 2020
    • Telehealth and the Impact on Cancer Care
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    Telehealth has arrived in full blossom throughout the healthcare industry as a silver-lining result in response to the COVID-19 pandemic. This panel will discuss the impact of telehealth on quality, access, and cost. Finally, the panel will end the discussion on the near and longer future of telehealth initiatives.

    Speakers

    Moderator

    • Ann Mond JohnsonCEO, ATA

    Faculty

    • Melissa Dillmon, MD, FASCOHematologist/Oncologist, Harbin Clinic Medical
    • Chevon Rariy, MDNational Director, Telehealth, Cancer Treatment Centers of America
    • Kim ThiboldeauxCEO, Cancer Support Community
    • Jason Tibbels, MDChief Quality Officer, Teledoc
    • Wednesday, November 18, 2020
    • The Future of Oncology Revenue Cycle Management and Precision Medicine Under Value-Based Care
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    Designing and implementing innovative value-based contracts represents challenges to all stakeholders in the cancer care ecosystem. In the future, value-based contracting initiatives will require insights into complex clinical data, utilization data, financial data, and administration costs harvested out of advanced electronic medical record and revenue cycle management systems. The current legacy systems and tools present major challenges to future innovation. The panel will discuss the future state and use cases and solutions needed to advance quality and value-based contracting.

    Speakers

    Moderator

    • Gail AirasianVP Sales & Services, Flatiron Health

    Faculty

    • Ron DiGiaimo, MBA, FACHEChairman of the Board, Revenue Cyle, Inc.
    • Brian GockermanManaging Director, Unlimited Systems
    • Christine HallVP, Revenue Cycle Management, American Oncology Network, LLC
    • Parag ShahPresident, Practice Solutions, Integra Connect
    • Thursday, November 19, 2020
    • Value-Based Contracting for Cancer Care
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    Payers and providers alike believe the future of healthcare reimbursement and access will lie in value-based contracting innovation. Value-based contracting has many definitions and meanings, depending on the stakeholder’s point of view, which makes designing and implementing the solutions more complex. Additionally, legacy ideas, systems, tools, and processes do not support the big vision deliverable. This panel will explore what is working, what has failed, and what lessons learned can be applied to future state value-based contracting.

    Speakers

    Moderator

    • Michael Kolodziej, MDSenior Advisor, ADVI Health

    Faculty

    • Brian Bourbeau, MBADivision Director, Practice Health Initiatives, American Society of Clinical Oncology
    • John Fox, MDFormer Associate VP, Medical Affairs, Priority Health
    • Brian Ragan, PharmD, BCPSValue-Based Contracting Executive, Humana
    • Bhuvana Sagar, MDNational Medical Executive, Cigna Health Care
    • Erin Smith, JDDirector II of Payment Innovation, Anthem
    • Friday, November 20, 2020
    • The Cancer Patient’s Message this Thanksgiving
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    No one truly knows what it is like to experience and navigate through the cancer care ecosystem unless you can experience it up-close and personal through your own eyes. Understanding this, we have put together a panel of patients who will share with us their up-close and personal experiences. We hope and trust that by putting these patient experiences out front through their lens, will help us better understand what we must do to improve upon the quality of care we deliver in the future.

    Speakers

    Moderator

    • Lillie Shockney, RN, BS, MAS, HON-ONN-CGFounder, Academy of Oncology Nurse & Patient Navigators

    Faculty

    • Patricia GoldsmithCEO, CancerCare
    • Molly MacDonaldFounder, Executive Director & Breast Cancer SurThrivor, The Pink Fund
    • Judy OchsSurvivor
    • Mimi SchnierProgram Assistant, SUNY Old Westbury
    • T.J. SharpeSpeaker, Writer & Patient Advisor, Starfish Harbor LLC
    • Monday, November 23, 2020
    • Patient Engagement and Cancer Care
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    More information coming soon.

    Speakers

    Moderator

    • Jayson Slotnik, JD, MPHManaging Partner, Health Policy Strategies

    Faculty

    • Fred BrownFounder, FAB Ventures
    • Bruce CarrollExperienced Government Relations Executive
    • Lily Tang, PhD, DABRCEO & Co-Founder, Liyfe Clinic
    • Srini UtpalaFounder & CEO, ATEY20
    • Tuesday, November 24, 2020
    • The Clinical Utility of Genomic Testing in Cancer Care
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    If oncologists are to be expected to use genomic tests in clinical practice, they must have a complete appreciation of their clinical utility. Clarifying the components of a modern definition of clinical utility of genomic testing in cancer that takes into account the full scope of benefits provided to patients and the healthcare system will allow healthcare decision makers to apply it in healthcare policy and clinical practice. In this session, panelists will seek to advance a state-of-the-art definition of clinical utility for genomic testing and discuss recommendations to ensure its appropriate implementation in cancer care.

    Speakers

    Moderator

    • Daryl Pritchard, PhDSVP, Science Policy, Personalized Medicine Coalition

    Faculty

    • Rachel Cunningham, PharmDDirector, Payer Policy and Health Outcomes, Foundation Medicine
    • Jamie Holloway, PhDSenior Director, Molecular Science Liaison, Caris Life Sciences
    • Casey O’NeillPrincipal, Oncology Marketing, Genentech
    • Jordi Rodon, MD, PhDAssociate Professor, MD Anderson Cancer Center
    • Monday, November 30, 2020
    • 340B Program Developments
    • 10th Association for Value-Based Cancer Care Summit

    Schedule

    • Live
    • 8:00 am – 9:00 am EST
    • 5:00 am – 6:00 am PST
    • Rebroadcast
    • 7:30 pm – 8:30 pm EST
    • 4:30 pm – 5:30 pm PST

    Overview

    More information coming soon.

    Speakers

    Moderator

    • Ted SlafskyFounder & Principal, Wexford Solutions

    Faculty

    • Chris Hatwig, MS, RPh, FASHPPresident, Apexus
    • Madeline Wallack, PhDFounding Director, Rx|X Consulting
    • Tuesday, December 1, 2020
    • Value-Based Contracting in the Pharma Space: Opportunities for Innovation and Overcoming Obstacles
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    There is little doubt that VBC is the future of healthcare, or the Pharmaceutical companies play a critical role in that development. But it takes multiple stakeholders to successfully change payment models from “fee for service” to VBC. Stakeholders need to align and all must comply with a complex maze of federal and state laws. This program will explore recent developments in the healthcare and drug spaces in an attempt to influence the future of VBC.

    Speakers

    Moderator

    • Jonathan Levitt, EsqCo-Founding Partner, Frier Levitt, LLC

    Faculty

    • Lili Brillstein, MPHCEO, Bcollaborative (Brillstein Collaborative Consulting)
    • Jesse Dresser, EsqPartner, Frier Levitt, LLC
    • Ira Klein, MD, MBA, FACPChief Medical Officer, Health New England
    • Roger LongmanChairman & Founder, Real Endpoints, LLC
    • Wednesday, December 2, 2020
    • Drug Benefit Reform and Cancer Care
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    Cancer care is complex and expensive, true, but drug benefit designs and coverages made for a one-size- fits-all approach is a less-than-perfect solution for cancer patients. Clearly, healthcare providers and sponsors are looking for meaningful reforms. What meaningful reform can we expect in a Trump or Biden administration? Is there an approach that could get broad support across all stakeholders? Or...are we doomed to perpetual handwringing? This panel will expose and debate the possibilities ahead.

    Speakers

    Moderators

    • Jayson Slotnik, JD, MPHManaging Partner, Health Policy Strategies
    • Burt Zweigenhaft, PhD, D.Litt.Managing Partner Upstream Partners, Co-Founder, AVBCC

    Faculty

    • Jaime Barnes, SM, BAVP, Value, Policy, Advocacy, and MS Commercial, TG Therapeutics, Inc.
    • Douglas Hoey, RPh, MBACEO, National Community Pharmacists Association
    • Anna Kaltenboeck, MASenior Health Economist & Program Director, Memorial Sloan Kettering Cancer Center
    • Ted Okon, MBAExecutive Director, Community Oncology Alliance
    • Drew Saelens, MBADirector, Government Affairs and Advocacy, Dendreon
    • Thursday, December 3, 2020
    • OCM Government Programs and Impact on Cancer Care
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    As one of the largest operational oncology value-based payment models, the Medicare Oncology Care Model (OCM) has been a driving force in the shift from volume to value in oncology care. However, opinions abound regarding what the Centers for Medicare & Medicaid Services (CMS) did right in the design of OCM and where there is room for improvement. In this session, we will facilitate a conversation among multiple OCM participant providers and CMS to understand what these stakeholders think was done right regarding OCM and where there are key opportunities for adjustment or innovation moving forward. We will aim to address the key questions of where CMS sees oncology value-based payment models in the future.

    Speakers

    Moderator

    • Pamela Pelizzari, MPHPrincipal & Healthcare Consultant, Milliman

    Faculty

    • Wendy AndrewsPractice Administrator, Oncology, University of Arizona Cancer Center
    • Blase Polite, MD, MPP, FASCOAssociate Professor of Medicine, University of Chicago
    • Ray Page, DO, PhD, FASCO, FACOIPresident, Center for Cancer and Blood Disorders, Texas - OCM Practice
    • Lara Strawbridge, MPHDirector, Division of Ambulatory Payment Models, Center for Medicare and Medicaid Innovation
    • Friday, December 4, 2020
    • Recognizing Better Outcomes in Stem Cell Transplantation
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    Stem Cell Transplantations (SCT) are poised for transformation with several innovations coming to market in the near term. SCT has been the standard of care for hematologic disorders for years, yet challenges remain. This panel will explore how to assess value of innovation within transplantation from a clinical, payer, and developer perspective.

    Speakers

    Moderator

    • Philip Cyr, SVP, Precision Value & Health

    Faculty

    • Steven Devine, MDAssociate Scientific Director & Senior Vice President, Research, Center for International Blood and Marrow Transplant Research® (CIBMTR); Chief Medical Officer, National Marrow Donor Program® (NMDP)/Be The Match®
    • John Fox, MD, MHASenior Advisor, PRECISIONvalue
    • Michele KorfinChief Operating Officer & Chief Commercial Officer, Gamida Cell
    • Tuesday, December 8, 2020
    • Oncology Drug Supply Chain Channels and the Move to Value
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    The speed of approval and complexity of new oncology drugs continues. With this, comes increasing demands from stakeholders to ensure the right diagnosis, the right drug selection, the right safety and monitoring, and the right programs to support patients on sustained therapy. There are more stakeholders than ever before, all of whom want real-time information. What are the current opportunities within these channels and what will be some breakout offerings within the next few years?

    Speakers

    Moderator

    • Burt Zweigenhaft, PhD, D.Litt.Co-Founder, Association for Value-Based Cancer Care

    Faculty

    • Dan DuranSVP & GM, Provider Solutions, Cardinal Health
    • Lisa Harrison, RPhPresident, Oncology Supply, AmerisourceBergen
    • Pete PerronPresident, Provider Solutions, McKesson Specialty Health
    • Will Pih, PharmDExecutive VP, Specialty Communications, Two Labs Marketing
    • Wednesday, December 9, 2020
    • Cancer Care: The Real-World Economics and Value Realities
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    Cancer care continues to be one of the most expensive disease states we have per capita, and drug costs continue to be the dominant cost center. The economics of cancer are complex as many cost centers and utilization paradigms have a profound effect on the total cost of care. The speakers will discuss, in detail, the underlying trends and economic realities of cancer in the US and global markets.

    Speakers

    Moderator

    • Burt Zweigenhaft, PhD, D.Litt.Co-Founder, Association for Value-Based Cancer Care

    Faculty

    • Murray Aitken, MBAExecutve Director, IQVIA Institute for Human Data Science
    • Ira Klein, MD, MBA, FACPChief Medical Officer, Health New England
    • Bruce Pyenson, FSA, MAAAPrincipal & Consulting Actuary, Milliman
    • Friday, December 11, 2020
    • Wall Street and Cancer Care
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    Capital markets fuel the investment and growth of cancer care innovation that is coming to market. The real-world economic impact for delivering this innovation to the marketplace needs to be balanced with the real-world realities of the cost, benefits, and value. This panel will share the Wall Street perspective on the opportunities and challenges ahead for cancer drug developers and cancer care providers alike.

    Speakers

    Moderator

    • Jody Hatcher, MBAFormer President, Vizient

    Faculty

    • Robert JonesGlobal Investment Research, Goldman Sachs
    • Ipsita Smolinski, MBAManaging Director, Capitol Street
    • Tuesday, December 15, 2020
    • Oncology Pharmacy Practice
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    Oncology therapeutics continue to be a dominant component of the treatment paradigm, and thus, specialized oncology pharmacy programs play an ever-increasing role in the complex delivery of care. Oncology pharmacy activity needs to be harmonized, not fragmented, with the patient’s overall core care team efforts. The panel will discuss the future state of medically integrated pharmacy and the benefits of this collaboration.

    Speakers

    Moderator

    • Michael Reff, RPh, MBAFounder & Executive Director, National Community Oncology Dispensing Association

    Faculty

    • Ray Bailey, BPharm, RPhPharmacy Director, Florida Cancer Specialists
    • Scott Freeswick, MS, PharmDVP & CPO, Memorial Sloan Kettering Cancer Center
    • Michael Ganio, PharmD, MS, FASHPSenior Director, Pharmacy Practice and Quality, American Society of Hospital Pharmacists
    • Chris Marcum, PharmDVP, Enterprise Pharmacy, Cancer Treatment Centers of America
    • Stacey McCullough, PharmDSVP, Pharmacy, Tennessee Oncology, LLC
    • Wednesday, December 16, 2020
    • COVID-19 Lessons Learned
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    COVID-19 wreaked havoc on the healthcare system and especially, the cancer care segment. The impact of COVID-19 will long be felt as not only did patients put off cancer screening, but the market expects late-term cancers to increase after decades long success of early detection. Additionally, providers needed to create new workflows and adopt telemedicine to supplement the practice paradigm. Unfortunately, no playbook existed, and cancer care providers had to innovate along the way to provide high quality cancer care. This panel will discuss the lessons learned and applied along with future state projections on care.

    Speakers

    Moderator

    • Michael Kolodziej, MDSenior Advisor, ADVI Health

    Faculty

    • Bruce Feinberg, DOVP & Chief Medical Officer, Cardinal Health Specialty Solutions
    • Barry Fortner, PhDFormer President, Specialty Physician Services, AmerisourceBergen
    • Patricia GoldsmithCEO, CancerCare
    • Debra Patt, MD, PhD, MBAExecutive VP, Policy and Strategic Initiatives, Texas Oncology
    • Vijay Trisal, MDChief Medical Officer, City of Hope
    • Linde Wilson, MBAChief Strategy Officer, Cancer Treatment Centers of America
    • Thursday, December 17, 2020
    • Oncology Nursing and Navigation
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    Oncology nurses and navigators are playing an ever-increasing important role in supporting the cancer patients and caregivers. This session will focus on the standardized measures and processes initiatives for supporting and improving the outcomes and care for the cancer patient and on the value derived.

    Speakers

    Moderator

    • Lillie Shockney, RN, BS, MAS, HON-ONN-CGFounder, Academy of Oncology Nurse & Patient Navigators

    Faculty

    • Andrea Dwyer, BSProgram Director, Colorado Cancer Screening Program
    • Sharon Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCNProgram Director, Academy of Oncology Nurse & Patient Navigators
    • Brenda Nevidjon, MSN, RN, FAANCEO, Oncology Nursing Society
    • Friday, December 18, 2020
    • Early-Stage Cancer Diagnosis and Trends
    • 10th Association for Value-Based Cancer Care Summit
    Next Event

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    More information coming soon.

    Speakers

    Moderator

    • Stan Skrzypczak, MS, MBAManaging Partner, 5 Prime Life Science Consulting, Inc.

    Faculty

    • Kathryn Lang, MDVP, Outcomes and Evidence, Guardant Health
    • J. Leonard Lichtenfeld, MD, MACPFormer Deputy Chief Medical Officer, American Cancer Society
    • Minetta Liu, MDOncologist, Mayo Clinic
    • Girish Putcha, MD, PhDChief Medical Officer, & Clinical Laboratory Director, Freenome
    • Monday, December 21, 2020
    • Prior Authorization and the Impact on Cancer Care
    • 10th Association for Value-Based Cancer Care Summit

    Schedule

    • Live
    • 8:00 am – 9:30 am EST
    • 5:00 am – 6:30 am PST
    • Rebroadcast
    • 7:30 pm – 9:00 pm EST
    • 4:30 pm – 6:00 pm PST

    Overview

    More information coming soon.

    Speakers

    Moderator

    • Bob Charles, MBASVP, Strategy and Innovation, D2 Consulting

    Faculty

    • Pending

    Latest Videos

    We Want to Know

    *Is access to care an obstacle for patients today?


    SPAM Check, leave blank

    Stay In The Know

    Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

    Subscribe
    © Amplity Health. All Rights Reserved. Privacy Policy.